AstraZeneca’s $1.1 Billion Acquisition of Icosavax

Centerview Partners LLC is serving as exclusive financial advisor to Icosavax and Goodwin is serving as legal counsel. Icosavax, Inc. (Nasdaq: ICVX) announced it has entered…

This content is for Standard 1 Year members only.
Login Join Now
Sonia Carcano

Author: Sonia Carcano

This content is for Standard 1 Year members only.
Login Join Now